Introduction {#Sec1}
============

According to estimates from the Global Burden of Disease 2010 Study, mental health-related disorders and cardiovascular disease (CVD) are the leading contributors to morbidity and mortality worldwide \[[@CR1], [@CR2]\]. Furthermore, mental health disorders including depression are associated with a greater incidence of coronary artery disease (CAD) and poorer prognosis after myocardial infarction (MI) and are generally more pronounced in women than men \[[@CR3]--[@CR10]\]. Sex differences in brain and physiological responses to stress in CAD patients may represent a mechanism for these differences between men and women in the incidence, prognosis, and pathophysiology of CAD.

Clinical characteristics of CAD and mental illness differ in men and women \[[@CR11]\]. Generally, while women younger than 65 years of age are less likely to develop CAD compared to men, once they are diagnosed with CAD, younger women tend to have a greater number of comorbidities and cardiovascular risk factors, longer duration of hospitalization for CAD, and greater risk of mortality within 30 days of hospitalization, even though they have less coronary atherosclerosis \[[@CR3], [@CR11]--[@CR20]\].

A clear distinction between women and men with CAD is that women have a higher burden of stress, depression, and anxiety \[[@CR21]--[@CR23]\]. Furthermore, recent experimental studies \[[@CR11], [@CR21], [@CR24]\] have shown that psychological stress may differentially or disproportionately affect women with CAD more than men. Mental stress-induced myocardial ischemia (MSI) is a phenomenon characterized by a demand-perfusion mismatch of the heart during a mental stress challenge \[[@CR25], [@CR26]\]. MSI is associated with poorer prognosis and increased mortality among patients with CAD. In a series of studies, we have shown that MSI is more common in women with CAD, especially young women, and that the underlying mechanisms may differ in women and men \[[@CR21], [@CR24], [@CR25], [@CR27]--[@CR29]\]

The neural pathways linking mental stress to CAD have only recently been the subject of investigation. Brain regions involved in emotion and cardiovascular regulation, including the medial prefrontal cortex, insula, and amygdala, have been hypothesized to play a role in MSI \[[@CR11]\]. Increased activity in the amygdala has been linked to both exposure to early stress \[[@CR30]--[@CR36]\] and PTSD \[[@CR30]--[@CR41]\] and the development of CVD \[[@CR42]\]. We have shown increased rostral anterior cingulate (medial prefrontal cortex) activation with stress in CAD patients with MSI \[[@CR43]\]. Prior imaging studies in conjunction with stress have shown sex differences in brain reactivity in healthy adults in brain areas involved in emotion, including the amygdala, hippocampus, and medial prefrontal cortex \[[@CR44]--[@CR46]\]. The neural correlates of stress comparing men and women with CAD, and with and without MSI, however, are not known. The objective of the present study was to investigate sex differences in neural correlates of mental stress and MSI in male and female patients with CAD. We addressed whether there are sex-related differences in the brain's response to mental stress in patients with CAD, and whether these differences are modified by MSI. We hypothesized that women would show greater activation with stress than men in brain areas involved in modulation of emotion, fear, and peripheral autonomic and stress reactivity, including amygdala, insula, and medial prefrontal cortex (anterior cingulate), and that these differences would be more pronounced in those subjects who develop MSI.

Methods {#Sec2}
=======

Study design {#Sec3}
------------

Participants were 60 female and 126 male patients with known CAD (*N* = 186) that were participants in the larger Mental Stress Ischemia Mechanisms and Prognosis Study (MIPS). Detailed methods for the MIPS cohort were described elsewhere \[[@CR47]\]. Briefly, 695 patients between 30 and 80 years of age with confirmed stable coronary artery disease (CAD) were prospectively enrolled between 2011 and 2014 from Emory University Hospital, Grady Memorial Hospital, and the Atlanta VA Medical Center. A clinical diagnosis of CAD was met if participants had angiographic evidence of CAD with at least one major vessel affected, a history of myocardial infarction, coronary bypass surgery or angioplasty, or a positive nuclear scan or exercise test. Patients were excluded from the current study if they had a history of a major psychiatric illness, based on the Structured Clinical Interview for the Diagnostic and Statistical Manual IV (SCID), including schizophrenia, schizoaffective, or bipolar disorder, and a recent history of alcohol or substance abuse or dependence in the past year. Patients were also excluded if they had a history of loss of consciousness exceeding 1 min, meningitis, neurological disorder such as Parkinson's disease or dementia, chronic oral steroid use or inhaled steroid use greater than 1500 μg/day, or antipsychotic, opiate, or benzodiazepine medication use within the past month. The parent study's aim, of the which this sample was a sub-group, was to over represent a history of depression so that approximately half of the sample would have depression (either current depressive episode or a Beck Depression Inventory score \> 13). For that reason and based on methodological considerations outlined elsewhere \[[@CR48]\], patients currently on antidepressant medications were not excluded from the study. Patients who were positive for MSI as part of the main MIPS protocol were also oversampled for the current study, resulting in roughly equivalent rates of MSI, unlike the parent study in which we have previously reported in this same sample higher rates of MSI in women, especially younger (\< 50) women \[[@CR21]\]. All patients underwent mental stress testing and myocardial perfusion during rest and stress was measured with Tc-99m sestamibi and Single Photon Emission Computed Tomography (SPECT) using a standardized protocol described previously in detail \[[@CR47]\]. All study subjects provided informed consent and the study was approved by the Emory University Institutional Review Board.

Psychometric assessments {#Sec4}
------------------------

The Structured Clinical Interview for DSM IV (SCID) \[[@CR49]\] was administered at the baseline visit by trained personnel to establish a depression diagnosis. Sociodemographic characteristics, medical history, and medication use were collected by a research nurse using standard questionnaires, chart reviews, and in-person interviews.

Mental stress testing {#Sec5}
---------------------

Subjects underwent eight PET brain imaging scans in conjunction with mental stress and control tasks in a single day. Participants were asked to hold beta-adrenergic antagonists and nitrate and calcium channel blockers for a minimum of 12--24 hours prior to mental stress testing. Subjects were scanned twice for each of the four tests (mental arithmetic control, public speaking control, mental arithmetic stress, and public speaking stress). After resting in a quiet room for 30 min, subjects were asked to perform the neutral control tasks and then the stressful tasks, each lasting approximately 2 min, and were scanned during each task. The order of the mental stresses was randomized. For the mental arithmetic control condition, participants were tasked with counting out loud. For the public speaking control condition, subjects discussed a neutral event. For the mental stress arithmetic task, participants were asked to solve a series of increasingly complex math problems under a time constraint and were given negative feedback regarding their performance by a white-coated staff member administering the test \[[@CR50]\]. To ensure that all participants experienced similar stress levels independent of personal skill, the difficulty level of arithmetic problems was increased until patients incorrectly answered three consecutive math problems. For the public speaking task, participants were provided two scripted scenarios of stressful interpersonal situations and instructed to develop a speech regarding these events. They were given 2 min to prepare each speech and three min to present it to an audience. Subjects were told that the content and duration of their speeches would later be evaluated.

Brain imaging during stress {#Sec6}
---------------------------

Subjects underwent high-resolution positron emission tomography (HR-PET) brain imaging with the high-resolution research tomograph (HRRT) (CTI, Knoxville, TN), with a spatial resolution of 2 mm \[[@CR51]\]. There was a total of eight brain scans, two scans during each of the two control (counting aloud and recalling a neutral event) and two stress (arithmetic and public speaking) conditions. Subjects were injected with 20 mCi of ^15^O water 10 s after the beginning of each task to assess brain function.

Myocardial perfusion imaging during stress {#Sec7}
------------------------------------------

On a separate day, subjects completed single-photon emission computed tomography (SPECT) cardiac imaging in conjunction with a public speaking task to measure myocardial perfusion at rest and with mental stress, using methods previously described as part of the MIPS protocol \[[@CR47]\]. Patients were injected with 10--14 mCi of \[Tc-99m\] sestamibi at rest, and SPECT images of the heart were acquired 30--45 min later. After resting for 30 min, patients completed the public speaking stress task and were injected with 30--40 mCi of \[Tc-99m\] sestamibi (depending on body weight) 1 min after beginning the task. Images were acquired 40--60 min later. Cardiac data were analyzed according to a 17-myocardial segments model and scored separately by two experienced readers, blinded to the task condition, and without prior knowledge of the subject's medical history, on a scale of 0 (normal) to 4 (no perfusion). Disagreements were resolved by consensus. Stress scores were calculated by adding numbers in rest and stress conditions and calculating the difference. Participants with a stress score of 3 or higher were determined to be positive for MSI, while those with a score lower than 3 were negative for MSI.

Hemodynamic reactivity {#Sec8}
----------------------

Hemodynamic reactivity measures were collected using an automatic oscillometric device. Measurements were recorded at baseline and during each control and mental stress task. The measurements obtained were averaged over the control and stress tasks to obtain mean control and mean mental stress measures. The mean rate pressure product during mental stress and control conditions for each subject was calculated as the product of the mean heart rate and the mean systolic blood pressure during control tasks and during mental stress tasks. Stress reactivity for systolic blood pressure, heart rate, and rate pressure product was calculated as the difference between mean mental stress and mean control measures.

Data analysis {#Sec9}
-------------

Differences in demographic and clinical variables between men and women were assessed using two sample *t* tests for continuous variables and Chi-square tests for categorical variables. The likelihood ratio test and twoway analysis of variance (ANOVA) were used to calculate the interaction of sex with MSI for categorical and continuous variables, respectively. Generalized linear modeling (GLM) was used to compare hemodynamic reactivity (heart rate, systolic blood pressure, and rate pressure product) between men and women, before and after adjusting for covariates. Variables sequentially added and adjusted for in the models included age, race, body mass index (BMI), history of myocardial infarction, history of heart failure, and antidepressant and beta-blocker use. Variables were selected for inclusion based on a priori considerations that they might confound the association, and they were retained if their inclusion caused at least a 10% change in the estimate for sex.

HR-PET images of brain activation and deactivation during stress in men and women with and without MSI in hypothesized regions (bilateral amygdala, insula, and anterior cingulate/medial prefrontal cortex) were processed using statistical parametric mapping (SPM8) software, following methods previously described \[[@CR52], [@CR53]\]. All scans were realigned to the first image in the scanning session, smoothed, and normalized onto a standard brain template from the Montreal Neurological Institute (MNI). First, an individual contrast map was created to identify areas of activation (stress--rest) or deactivation (rest--stress). For the purposes of this study, all control and mental stress tasks were averaged across type. Contrast maps were then computed across between-subject factors (gender, MSI). A two-layered mask was applied to each gender difference by MSI contrast. First, an exclusive mask was applied based upon significant differences during control tasks (Additional file [1](#MOESM1){ref-type="media"}: Table S1). Second, an inclusive mask was applied based on the within-gender significant activations or deactivations (Additional file [1](#MOESM1){ref-type="media"}: Tables S2--S5) as a result of mental stress. All brain activations were controlled for African-American race, presence of depression, usage of anti-depressants, diuretics, beta-blockers, and history of heart failure. Areas of significant differences based on gender and task were displayed using mricron ([nitrc.org/projects/mricron](http://nitrc.org/projects/mricron)) with standard stereotactical coordinates \[[@CR54]\]. Significance MSI and gender contrast thresholds were set at *p* \< 0.005 and 11 contiguous voxels in brain regions to minimize risk of Type 1 and Type 11 errors \[[@CR55]\] with the exception being within-gender activation/deactivation maps which were family-wise error corrected given the nature of a single main effect regressor contrast using this analytical pipeline \[[@CR56]\]. Areas of significant differences based on sex and task were displayed using SPM8 with standard stereotactical coordinates \[[@CR54]\]. Significance thresholds were set at *p* \< 0.005 and 11 contiguous voxels in brain regions to minimize risk of Type 1 and Type 11 errors \[[@CR55]\].

Results {#Sec10}
=======

Of the 186 individuals enrolled in the study, 7 women and 14 men were excluded due to either poor scan quality or incomplete scans. The final analysis included 53 women and 112 men with a mean (± standard deviation) age of 61.2 ± 7.7 and 62.3 ± 8.7, respectively. The proportion of African-Americans was nearly twofold greater among women than men (Table [1](#Tab1){ref-type="table"} in the "Appendix" section). Women were also more likely to have had heart failure and major depression in their lifetime and to be treated with antidepressant, beta-blocker, and diuretic medications. All other select demographic, clinical, and lifestyle characteristics were evenly distributed among men and women in the dataset, even after stratifying for MSI status (Table [1](#Tab1){ref-type="table"} in Appendix).

Men and women did not differ significantly in hemodynamic reactivity to psychosocial stress testing (Table [2](#Tab2){ref-type="table"} in Appendix). At baseline, women, compared to men, had significantly higher heart rate (mean ± standard deviation, 67 ± 10 vs 63 ± 10 bpm, *p* = 0.01) and rate pressure product (9359 ± 1951 vs 8456 ± 1661, *p* = 0.002). During mental stress, women displayed greater average heart rate compared to men (78 ± 13 vs 74 ± 13 bpm, *p* = 0.04). However, there were no statistically significant sex differences in either systolic blood pressure, heart rate or rate pressure product reactivity to mental stress in both unadjusted and adjusted models.

Women had greater baseline activity during the neutral tasks (Additional file [1](#MOESM1){ref-type="media"}: Table S1) in the occipital lobe, temporal lobe, parietal lobe, and cerebellum. To account for these differences, only areas outside of the baseline differences were considered to be altered as a result of mental stress. Across the entire sample, men and women showed different neural activation and deactivation in response to mental stress, compared to control conditions. Compared to men, women showed greater activation in the left temporal/fusiform gyrus (BA 37), right parietal lobe (BA 3, 6, 40), right frontal lobe (BA 9, 44), right posterior cingulate gyrus (BA 31), and bilateral cerebellum during mental stress compared to control tasks (Table [3](#Tab3){ref-type="table"} in Appendix). However, women had greater deactivation than men to mental stress testing in multiple corticolimbic and related structures, including the bilateral anterior cingulate gyrus (BA 24, 32), bilateral medial frontal gyrus (BA 6, 8, 9, 10), right parahippocampal gyrus, and right middle temporal gyrus (BA 21; Table [3](#Tab3){ref-type="table"} in Appendix).

Sex differences in neural reactivity to mental stress also differed by MSI status. Among participants without MSI, sex differences during stress compared to control were observed in the left cerebellum and right superior parietal lobe (Table [4](#Tab4){ref-type="table"} in Appendix, Fig. [1](#Fig1){ref-type="fig"}). In contrast, women with MSI showed greater activation than men with MSI with stress in many brain areas including the right posterior cingulate gyrus (BA 31), right parietal lobe (BA 3, 7, 40), bilateral frontal lobe (BA 6, 8, 9, 10, 11, 44), left temporal lobe (BA 39), and bilateral posterior cerebellum (Table [5](#Tab5){ref-type="table"} in Appendix, Figs. [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}). Furthermore, women with MSI also had greater deactivation with stress, relative to men with MSI, in the right middle temporal gyrus (BA 21), bilateral superior frontal gyrus (BA 6, 7, 8), bilateral middle frontal gyrus (BA 6, 8, 11), bilateral medial frontal gyrus (BA 6, 9, 10), and the bilateral inferior frontal gyrus (BA 45, 47).Fig. 1Study diagram for days 1 and 2 of the protocol. On day 1, subjects get an injection of \[Tc99m\] sestamibi followed by SPECT imaging of the heart at rest. Three hours later they undergo speech mental stress followed by injection of \[Tc99m\] sestamibi and SPECT imaging of the heart with mental stress. On the second day, subjects undergo HR-PET imaging of the brain with stress and control conditions. Subjects undergo eight HR-PET scans after injection of 20 mCi O-15 water, 2 with counting control, 2 with speech control, 2 with arithmetic mental stress, and 2 with speech mental stressFig. 2Brain areas with greater (*p* \< 0.005) cerebral blood flow increases (activation) during mental stress compared to control tasks in women (*n* = 44) versus men (*n* = 77) with coronary artery disease but no mental stress induced myocardial ischemia using \[^15^O\]H~2~O positron emission tomography. Values below brain denote Talairach coordinates. Color bars indicate *Z* values of activation or deactivationFig. 3Sagittal brain slices representing greater (*p* \< 0.005) cerebral blood flow increases (activation; red) and decreases (deactivation; blue) during mental stress compared to control tasks in women (*n* = 9) versus men (*n* = 35) with coronary artery disease and mental stress induced myocardial ischemia using \[^15^O\]H~2~O positron emission tomography. Values below brain denote Talairach x-coordinates, where positive and negative values correspond to the right and left hemisphere, respectively. Color bars indicate *Z* values of activation or deactivation

Discussion {#Sec11}
==========

This study showed unique patterns of brain response to stress in men and women with mental stress-induced myocardial ischemia (MSI) compared to non-MSI. Women without MSI had focal but scant increases in activation/deactivation compared to men without MSI. Women with MSI, however, showed widespread changes in brain activity compared to men with MSI including activation of the anterior cingulate, right parietal lobe, and bilateral frontal lobe with stress, and greater deactivations in temporal cortex, amygdala, and superior and inferior, medial, and middle frontal gyrus. These differences were seen in spite of the fact that men and women showed similar cardiovascular reactivity to stress.

The anterior cingulate plays a pivotal role in both the regulation of emotion and peripheral autonomic and cardiovascular responses to stress \[[@CR57], [@CR58]\]. In addition to activating peripheral cardiovascular responses that could lead to MSI, this region is involved in the inhibition of fear responses in the amygdala and the extinction of fear \[[@CR59]--[@CR62]\]. Previous studies have shown that chronic stress alters functional reactivity of the cingulate cortex and other subsets of the limbic system to stress \[[@CR63], [@CR64]\]. Studies in patients with stress-related psychiatric disorders including PTSD and depression (that have also been linked to cardiovascular disease) \[[@CR65], [@CR66]\] found decreases in stress-responsive activation in this area as well as smaller volume \[[@CR67]--[@CR69]\]. In the current study, mental stress was associated with significantly greater deactivation of the left anterior cingulate cortex in women with CAD compared to men with CAD. Greater anterior cingulate deactivations were only observed in those with MSI, as women with CAD and MSI had bilateral deactivations within the anterior cingulate compared to men with CAD.. These results suggest that dysregulation of the anterior cingulate gyrus could be involved in pathways linking mental stress to myocardial ischemia and cardiovascular-related death \[[@CR70]\]. The results further suggest that there are differences between men and women, both in those with and without MSI. These findings may help explain why women are at increased risk compared to men for both stress-related psychiatric disorders and MSI.

Unique patterns of brain activation in women versus men with MSI could translate into differences in peripheral stress-responsive neurohormonal and cardiovascular systems. The central autonomic network contributes to the regulation of the autonomic nervous system and has sympathetic and parasympathetic system network subdivisions \[[@CR71]\]. In the current study, stress resulted in greater deactivation in brain regions associated with sympathetic regulation (posterior and mid cingulate cortex) as well as greater activation in brain areas tied to parasympathetic regulation (cerebellum) \[[@CR72], [@CR73]\] in women with CAD than men with CAD. This relationship appears to occur only in those with MSI. Furthermore, the default mode network, brain regions engaged while performing passive tasks, were also more deactivated in women than men with CAD. Brain areas of the default mode network include the lateral temporal cortex and dorsal medial prefrontal cortex and are involved in functions such as introspection and exploration during low attention-requiring tasks \[[@CR74]\]. Our results suggest that women may have been more task-focused and less engaged in internal meditations than men in response to heightened psychosocial stress, and that mechanisms of autonomic regulation in response to stress may differ in men and women.

Men and women had many similar increases in activation and deactivation to psychosocial stress in brain regions that contribute to the execution of emotionally and cognitively stressful tasks. This included areas implicated in mental arithmetic, phonological language processing, visual processing, spatial awareness, working memory, and emotion regulation (middle frontal gyrus, superior frontal gyrus, inferior parietal lobe, supramarginal gyrus, and cingulate gyrus) \[[@CR75]--[@CR81]\]. Women with CAD, however, showed greater activation in response to mental stress in a brain region implicated in language processing (middle temporal gyrus) \[[@CR78]\] when compared to men with CAD. Interestingly, mental stress resulted in a greater decrease in blood flow in women than men in brain regions that contributed to the regulation of language and literacy, vision and eye movement, and social cognition (right middle temporal gyrus, BA 21, medial frontal gyrus, BA 8 and 9) \[[@CR82], [@CR83]\] and most notably, anterior cingulate gyrus.

Our study provides a foundation for the identification of neural biomarkers of mental stress in men and women with CAD. Our study, however, had limitations worth noting. Participants may have exerted themselves differently during performance of stress or control tasks and this may be a confounder. Men and women in this study differed in several variables, including race and antidepressant usage. These variables, however, may be independently associated with MSI. For instance, women have twice the rates of stress-related psychiatric disorders than men \[[@CR84]\], and African-American women with CAD are particularly at risk \[[@CR85]\], which may explain higher rates of antidepressant usage as well as MSI. Additionally, we have found that MSI is most common in women, and in particular younger women \[[@CR24], [@CR28], [@CR29]\], with a predilection for African-American women, a finding from the parent study of the current cohort \[[@CR21]\]. These may represent, therefore, co-variables with sex-based differences in effects of stress on the brain. The findings persisted, however, after controlling for these variables. Another limitation of this study is that the only patients with CAD were included, therefore our results are only generalizable to patient populations with CAD. The findings, however, offer suggestive evidence that differences between men and women in how brain areas modulating emotion, notably the anterior cingulate, respond to stress, may offer clues about differences in stress-induced myocardial ischemia.

Perspectives and significance {#Sec12}
=============================

The results of this study indicate that neural correlates of mental stress differ between men and women with CAD, with greater deactivation in women in multiple regions including the anterior cingulate gyrus, a brain region involved in emotional and autonomic regulation, compared to men. These findings related to the anterior cingulate carry over in the comparison between men and women with stress-induced myocardial ischemia. The findings suggest a possible mechanism for important differences between men and women in stress-induced myocardial ischemia, notably that women, especially younger women, may be more susceptible to this phenomenon. The clinical relevance of this is that stress-induced myocardial ischemia may require different treatment approaches than exercise-induced ischemia, such as relaxation training, meditation, biofeedback, or other behavioral approaches. Furthermore, the worse prognosis of these patients, especially for younger women with stress-induced myocardial ischemia than for men and/or exercise-induced ischemia, illustrates the importance of focused approaches to these patients to ensure optimal outcomes.

Additional file {#Sec14}
---------------

Additional file 1:Additional tables. (DOCX 59 kb)

Appendix {#Sec13}
========

Table 1Demographic and clinical characteristics of study participants by sex (*N* = 165)WomenMen*P*(*n* = 53)(*n* = 112)Demography Age, y ± SD61.2 ± 7.762.3 ± 8.70.42 African-American, %29 (55)32 (29)*0.001* Education (high school)12 (23)33 (29)0.36Clinical Characteristics and Lifestyle Factors BMI, ± SD31.2 ± 7.429.5 ± 5.20.09 Current major depressive episode, SCID, %17 (32)24 (22)0.16 Lifetime major depression, SCID, %31 (58)37 (33)*0.002* Abnormal angiogram37 (76)66 (60)0.06 Abnormal nuclear test7 (14)14 (13)0.79 Abnormal exercise test, %9 (18)13 (12)0.27 Diabetes, %19 (36)38 (34)0.81 Dyslipidemia, %40 (75)96 (86)0.11 Heart Failure, %14 (26)12 (11)*0.01* Hypertension, %40 (75)85 (76)0.95 MI History, %16 (30)47 (42)0.15 MSI, %9 (17)35 (31)*0.05* Smoking History  Current Smoker, %7 (14)16 (15)0.31  Former Smoker, %21 (43)60 (54)  Never Smoker, %21 (38)34 (31)Medication Use ACE Inhibitors, %21 (40)52 (47)0.38 Antidepressants, %26 (50)29 (26)*0.003* Aspirin, %45 (85)96 (86)0.78 Beta Blockers, %45 (85)77 (69)*0.03* Diuretics, %24 (45)26 (23)*0.004* Statins, %41 (84)99 (91)0.19 Vasodilators, %5 (9)12 (11)0.79*Abbreviations*: *SPECT* single photon emission computed tomography, *MSI* mental stress ischemia, *BMI* body mass index, *SCID* Structured Clinical Interview for DSM IV, *MI* myocardial infarction

Table 2Sex differences in hemodynamic reactivity parameters in response to mental stress, unadjusted (*N* = 165)Women (*n* = 53)Men (112)*P* valueMean ± SDMean ± SDSystolic blood pressure (mmHg) Control140 ± 22135 ± 150.07 Stress162 ± 27161 ± 210.91 Systolic blood pressure reactivity22 ± 1727 ± 160.07Heart rate (bmp) Control67 ± 1063 ± 10*0.01* Stress78 ± 1374 ± 13*0.04* Heart rate reactivity11 ± 911 ± 70.81Rate pressure product (mmHg\*bmp) Control9359 ± 19518456 ± 1661*0.002* Stress12,676 ± 306511,874 ± 26670.08 Rate pressure product reactivity3315 ± 21553391 ± 21120.82*SD* standard deviation^\*^Statistical tests: Student t test or Wilcoxon--Mann--Whitney U test, when appropriate

Table 3Brain regions with significantly (one tailed *Z* \> 2.75, *p* \< 0.005) greater mental stress-induced activation or deactivation in women (*n* = 53) relative to men (*n* = 112) with coronary artery disease as measured with \[^15^O\]H~2~O positron emission tomographyVoxel numberBrain regionsBrodmann's areaTalairach*Z* score*XYZ*Greater stress activation in women than men 22L cerebellum− 26− 40− 185.26 86L cerebellum− 18− 69− 184.85L cerebellum− 16− 76− 133.61 42R parietal lobe, postcentral gyrus4051− 32504.75 26R cerebellum46− 63− 194.25 36R cerebellum10− 72− 104.25 11R parietal lobe, postcentral gyrus353− 9494.13R frontal lobe, precentral gyrus648− 7542.82 96L cerebellum− 44− 48− 263.87L cerebellum− 48− 40− 323.52 66R posterior cingulate318− 43393.74R parietal lobe, precuneus74− 51383.54 12L occipital lobe, fusiform gyrus19− 42− 65− 93.73 14R frontal lobe, precentral gyrus659− 10423.72 22R cerebellum24− 50− 233.56 19R frontal lobe, superior gyrus94237323.55R frontal lobe, middle gyrus94246262.66 33R parietal lobe, inferior lobule4048− 58483.53 68R parietal lobe, superior lobule730− 59533.51R parietal lobe, inferior lobule4038− 52533.38 19R cerebellum22− 75− 153.47 32L temporal lobe, fusiform gyrus37− 50− 61− 173.44 12R frontal lobe, precentral gyrus445910133.28Greater stress deactivation in women than men 23L anterior cingulate24− 423245.02 51R frontal lobe, superior gyrus61422515.00 95R frontal lobe, inferior gyrus472422− 204.67R frontal lobe, orbital gyrus472230− 233.07 64L frontal lobe, medial gyrus6− 1429364.63L frontal lobe, superior gyrus8− 1032473.50 86R frontal lobe, inferior gyrus474427− 84.53R frontal lobe, inferior gyrus475028− 134.04 46L frontal lobe, superior gyrus6− 614554.46L frontal lobe, superior gyrus6011583.25 28L parietal lobe, supramarginal gyrus40− 63− 43274.39L temporal lobe, supramarginal gyrus40− 63− 51233.35 49L frontal lobe, inferior gyrus− 531814.06 17L parietal lobe, superior lobule7− 26− 64504.00 32R temporal lobe, middle gyrus2169− 45− 83.99 37L parietal lobe, precuneus7− 14− 44593.84 26R frontal lobe, medial gyrus92238233.84 34L frontal lobe, medial gyrus10− 65573.81 34R temporal lobe, middle gyrus2161− 3− 173.74 11R anterior cingulate32227343.73 26R frontal lobe, subcallosal gyrus34187− 123.68 13L frontal lobe, superior gyrus8028493.67 36R frontal lobe, medial gyrus101055173.55R frontal lobe, medial gyrus9246182.82 51R frontal lobe, middle gyrus114242− 193.54R frontal lobe, middle gyrus113852− 143.42 31L parietal lobe, postcentral gyrus5− 30− 44583.53 14L frontal lobe, middle gyrus6− 3812463.53 14L frontal lobe, inferior gyrus45− 591863.50 18L frontal lobe, precentral gyrus4− 44− 18333.46 13L frontal lobe, superior gyrus8− 2216483.44 24R frontal lobe, middle gyrus83016413.33 29R parietal lobe, supramarginal gyrus4057− 47313.30R parietal lobe, inferior lobule4051− 51383.15 11L parietal lobe, precuneus7− 10− 40473.27 12R frontal lobe, medial gyrus10254− 93.15 15L parietal lobe, postcentral gyrus3− 28− 23463.13 11L frontal lobe, inferior gyrus− 404332.99 17L frontal lobe, middle gyrus11− 3850− 142.95 13R parahippocampal gyrus308− 3972.77

Table 4Brain regions with significantly (one tailed *Z* \> 2.75, *p* \< 0.005) greater mental stress-induced activation or deactivation, as measured with \[^15^O\]H~2~O positron emission tomography, in women (*n* = 44) relative to men (*n* = 77) participants with CAD but not mental stress-induced myocardial ischemiaVoxel numberBrain regionBrodmann's areaTalairach*Z* score*XYZ*Stress activation in women \> men13L cerebellum− 44− 50− 343.5617R parietal lobe, superior lobule730− 63533.19R parietal lobe, superior lobule734− 56553.12

Table 5Brain regions with significantly (one tailed *Z* \> 2.75, *p* \< 0.005) greater mental stress-induced activation or deactivation, as measured with \[^15^O\]H~2~O positron emission tomography, in women (*n* = 9) relative to men (*n* = 35) with CAD and mental stress-induced myocardial ischemiaVoxel numberBrain regionBrodmann's areaTalairach*Z* score*XYZ*Stress activation in women \> men 24L cerebellum− 26− 40− 185.70 54R parietal lobe, postcentral gyrus4051− 32505.44 112L cerebellum− 18− 69− 185.05L cerebellum− 14− 76− 133.54 67R parietal lobe, inferior lobule4048− 58464.97 35R cerebellum46− 63− 194.53 33R cerebellum10− 72− 104.38 112R posterior cingulate318− 43414.35R parietal lobe, precuneus74− 51384.18 12L occipital lobe, fusiform gyrus19− 42− 65− 94.13 110L cerebellum− 46− 38− 324.07L cerebellum− 44− 48− 253.33L cerebellum− 53− 44− 353.14 47L cerebellum− 42− 61− 174.02 36R frontal lobe, inferior gyrus445912133.91 14R temporal lobe, middle gyrus3940− 65153.81 15R parietal lobe, postcentral gyrus359− 13443.77 20R frontal lobe, superior gyrus94237323.66 15L frontal lobe, superior gyrus10− 2263123.54 19R cerebellum24− 50− 243.54 41R parietal lobe, inferior lobule4038− 52533.48 15L frontal lobe, middle gyrus11− 2432− 123.37 13R frontal lobe, superior gyrus81448363.33 12L parietal lobe, inferior lobule40− 61− 33333.26 14R cerebellum22− 75− 153.18 14R frontal lobe, superior gyrus104248232.89Stress deactivation in women \> men 129R frontal lobe, inferior gyrus472422− 205.66R frontal lobe, orbital gyrus472230− 234.01 51R frontal lobe, superior gyrus61422515.47 37L frontal lobe, medial gyrus6− 1429364.95 88R frontal lobe, inferior gyrus474427− 64.94R frontal lobe, inferior gyrus475034− 153.80 33L parietal lobe, supramarginal gyrus40− 63− 43274.91 52L frontal lobe, superior gyrus6− 412554.56 24L anterior cingulate24− 423244.54 17L parietal lobe, superior lobule7− 26− 64504.41 42R temporal lobe, middle gyrus2169− 45− 84.25R temporal lobe, inferior gyrus2067− 47− 152.82 69L parietal lobe postcentral gyrus40− 26− 38494.20L parietal lobe, postcentral gyrus5− 30− 44583.75 30L frontal lobe, precentral gyrus44− 631294.17L frontal lobe, inferior gyrus45− 591863.94 53R temporal lobe, inferior gyrus2161− 9− 164.16 54R frontal lobe, subcallosal gyrus34167− 144.15 24R frontal lobe, medial gyrus92238234.04 14L frontal lobe, superior gyrus8028493.98 53L frontal lobe, inferior gyrus− 531813.97L frontal lobe, inferior gyrus47− 4614− 13.15 46R frontal lobe, medial gyrus101053163.97 26R frontal lobe, middle gyrus82816433.93R frontal lobe, middle gyrus82422463.24 15L frontal lobe, superior gyrus8− 2216483.83 86R frontal lobe, middle gyrus104450− 73.80R frontal lobe, middle gyrus114046− 173.63 32L thalamus− 16− 2733.78 32R parietal lobe, supramarginal gyrus4059− 47293.73R parietal lobe, inferior lobule4051− 52383.60 11R limbic lobe, cingulate gyrus32227343.72 30R temporal lobe, superior gyrus225112− 23.70R temporal lobe, superior gyrus384613− 93.62 35L frontal lobe, paracentral lobule5− 12− 42593.69 31L frontal lobe, medial gyrus10− 65573.64 20R lentiform nucleus16− 753.61 34L frontal lobe, paracentral lobule5− 6− 38523.61L parietal lobe, precuneus7− 12− 42473.53 51R posterior cingulate294− 36133.53 12L frontal lobe, middle gyrus6− 3812463.41 18R anterior cingulate2549− 73.39 14L frontal lobe, inferior gyrus10− 424533.39 20L frontal lobe, precentral gyrus4− 44− 18363.39 12L frontal lobe, precentral gyrus4− 36− 24553.38 22L parietal lobe, postcentral gyrus3− 30− 27423.26 22R frontal lobe, medial gyrus62− 22633.25 27L frontal lobe, medial gyrus8− 1231453.22L anterior cingulate32− 1022443.22 13R frontal lobe, medial gyrus11254− 113.20 11R lentiform nucleus32− 1323.19 17R frontal lobe, paracentral Lobule58− 34543.15R frontal lobe, paracentral lobule514− 34492.93 21L frontal lobe, orbital gyrus11− 644− 193.10

ANOVA

:   Analysis of variance

BA

:   Brodmann's area

BMI

:   Body mass index

CAD

:   Coronary artery disease

CVD

:   Cardiovascular disease

DSM-5

:   Diagnostic and Statistical Manual -- 5

FDA

:   Food and Drug Administration

GLM

:   general linear model

HR-PET

:   High-resolution positron emission tomography

MI

:   Myocardial infarction

MNI

:   Montreal Neurological Institute

MRI

:   Magnetic resonance imaging

MSI

:   Mental stress ischemia

PET

:   Positron emission tomography

SCID

:   Structured Clinical Interview for DSM-5

SPECT

:   Single-photon emission computed tomography

SPM8

:   Statistical parametric mapping - 8
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